Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Endometrial Neoplasms × durvalumab × Clear all

Phase

Phase 2 5 Phase 3 2 Phase 1 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 2 Small Cell Lung Carcinoma 1 Liver Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Early Intervention, Educational 8 Indocyanine Green 7 Surveys and Questionnaires 6 Methods 6 Sentinel Lymph Node Biopsy 5 Lymph Node Excision 5 Exercise 5 Counseling 5 Robotic Surgical Procedures 4 Genetic Testing 4 Blood Specimen Collection 4 Radiotherapy 3 Radiation 3 Psychiatric Rehabilitation 3 Motivational Interviewing 3 Diet 3 Behavior Therapy 3 iso-sulfan blue 2 Videotape Recording 2 Trehalase 2 Therapeutics 2 Surgical Procedures, Operative 2 Standard of Care 2 Palliative Care 2 Paclitaxel 2 Megestrol Acetate 2 Laparoscopy 2 Interviews as Topic 2 Injections 2 Genetic Counseling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04444193 2020-06-23

Dulect2020-2

Shanghai First Maternity and Infant Hospital

Phase NA Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡